Stock Splits
By The Online Investor Staff, updated Tue., May. 24, 9:17 AM
| This Slide: #10 of 25 |
Slide #10. Evofem Biosciences, Inc. (NASDAQ:EVFM) — 1 for 15 Reverse Split
Announced:
5/5/2022
Stock Split:
1 for 15
Record Date:
5/5/2022
Pay Date:
5/6/2022
EVFM Optionable?:
Yes
Evofem Biosciences is a biopharmaceutical company committed to developing and commercializing products to address unmet needs in women's sexual and reproductive health. Co. is utilizing its proprietary Multipurpose Vaginal pH Regulator (MVP-R™) platform to product candidates for several potential indications, including prevention of pregnancy and prevention of certain sexually transmitted infections. Co. is developing its primary MVP-R product candidate, Phexxi™, a non-hormonal, woman-controlled vaginal gel, for three potential indications: prevention of pregnancy, prevention of urogenital Chlamydia trachomatis infection and prevention of urogenital Neisseria gonorrhoeae infection. 
EVFM Detailed Information Page & Split History »
|
|||||||||||||||||||||
Open the EVFM Page at The Online Investor (in a new window) »
 Free EVFM Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
 
|
Buy (3.17 out of 4) 27th percentile
(ranked lower than approx. 73% of all stocks covered)
Analysts' Target Price: EVFM Stock Forecast Based on Zacks ABR data; powered by Xignite |
